BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Empirico

Empirico logo

Founded
2017
Patents
9
Publications
1

Technologies

AI Companies (Drug Discovery)

A Next Generation Therapeutics Company. Empirico is a venture-backed, next-generation therapeutics company founded on utilizing huge biological data sets, human genetics and programmable biology to power novel target discovery and development. Empirico’s Precision Insights Platform was purpose-built for therapeutic discovery and leverages a world-leading dataset and advanced algorithmic approaches to identify and prioritize therapeutic targets with a high probability of translational success. High priority therapeutic targets are experimentally validated in-house prior to progressing through pre-clinical development with the most optimal therapeutic modality.

Become a Member to view additional information about this company